Qiagen NV(QGEN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 10 at 4:00 PM ET (Korea 9/11 05:00)
Full metrics table
| Index | - | P/E | 21.4 | EPS (ttm) | 1.97 | Insider Own | 0.6% | Shs Outstand | 206.5M | Perf Week | -4.68% |
| Market Cap | 8.68B | Forward P/E | 16.13 | EPS next Y | 7.65% | Insider Trans | - | Shs Float | 204.8M | Perf Month | -1.22% |
| Enterprise Value | 9.53B | PEG | 2.57 | EPS next Q | 0.62 | Inst Own | 77.98% | Short Float | 4.95% | Perf Quarter | 13.8% |
| Income | 0.41B | P/S | 4.13 | EPS this Y | 1.92% | Inst Trans | -3% | Short Ratio | 3.53 | Perf Half Y | 2.23% |
| Sales | 2.10B | P/B | 2.59 | EPS next 5Y | 6.27% | ROA | 6.99% | Short Interest | 10.14M | Perf YTD | -6.22% |
| Book/sh | 16.26 | P/C | 10.94 | EPS past 3/5Y | -0.15% 3.6% | ROE | 11.93% | 52W High | -27.13% ($57.81) | Perf Year | -8.34% |
| Cash/sh | 3.85 | P/FCF | 19.39 | Sales past 3/5Y | -0.81% 2.25% | ROIC | 8.21% | 52W Low | 29.51% ($32.53) | Perf 3Y | 1.38% |
| Dividend Est. | $0.26 (0.62%) | EV/EBITDA | 13.25 | EPS Y/Y TTM | 9.52% | Gross Margin | 61.8% | Volatility(W/M) | 2.24% 2.52% | Perf 5Y | -23.97% |
| Dividend TTM | 0.35 | EV/Sales | 4.54 | Sales Y/Y TTM | 2.96% | Oper. Margin | 24.62% | ATR (14) | 1.18 | Perf 10Y | 61.99% |
| Dividend Ex-Date | 2026/7/7 | Quick Ratio | 2.31 | EPS Q/Q | 7.13% | Profit Margin | 19.49% | RSI (14) | 45.92 | Recom | 2.27 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.85 | Sales Q/Q | 0.28% | SMA20 | -2.64% ($43.27) | Beta | 0.62 | Target Price | $45.83 |
| Payout | 12.88% | Debt/Eq | 0.49 | Earnings | 2026/8/5 | SMA50 | 0.14% ($42.07) | Rel Volume | 0.43 | Prev Close | $42.5 |
| Employees | 5654 | LT Debt/Eq | 0.48 | EPS/Sales Surpr. | 3.61% 1.43% | SMA200 | -1.31% ($42.69) | Avg Volume(3M) | 2.87M | Price | $42.13 |
| IPO | 1996/6/28 | Option/Short | Yes/Yes | Trades | 11550 | Volume | 1,246,254 | Change | -0.87% |
Company
QGEN is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🧫 This is a global life sciences and diagnostics company that provides molecular diagnostics and sample preparation and analysis technologies. It supplies kits and equipment for extracting and analyzing genetic information from samples, as well as diagnostic tests for tuberculosis and infectious diseases. The company's results are tied to recurring consumables demand and diagnostic and research demand, making it a diagnostics and life sciences play.
Over the past 1 year, roughly in the middle
27% below its 1-year high.
QGEN makes money exceptionally well
24.62% of revenue is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +1.9% this year.
Tap to view numbers
The price looks about right
Trading at 21.4 times earnings.
Tap to view numbers
Results came in about as expected
Generally in line with estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +1.4% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 0.62% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 78.0%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
GNOM 0.04%
EKG 0.03%
PBE 0.02%
FXH 0.01%
GDOC 0.01%It ranks #4 in the industry
Based on market cap of $9B.
QGEN $9B PER 21.4
TMO $223B PER 32.5
DHR $141B PER 35.6
NTRA $47B PER -
FAQ
What kind of company is QGEN?
QGEN belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of QGEN?
The market cap of QGEN is approximately $8.7B, ranking 1,032 within its sector.
Does QGEN pay dividends?
QGEN has a dividend yield of approximately 0.62%, with an annual dividend of $0.26.
What is the P/E ratio of QGEN?
QGEN has a P/E ratio of approximately 21.4x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for QGEN?
QGEN has recorded a 52-week high of $57.81 and a low of $32.53.
